These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 21727749

  • 1. Diabetes and Ramadan: an update on use of glycemic therapies during fasting.
    Ahmed MH, Abdu TA.
    Ann Saudi Med; 2011; 31(4):402-6. PubMed ID: 21727749
    [Abstract] [Full Text] [Related]

  • 2. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A, Zantout MS, Azar ST.
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [Abstract] [Full Text] [Related]

  • 3. A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting.
    Rashid F, Abdelgadir E.
    Diabetes Metab Syndr; 2019 Aug; 13(2):1413-1429. PubMed ID: 31336501
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R, Alsubaiee M, Alqarni A, Saleh Y, Aljaser S, Salam A, Eledrisi M.
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [Abstract] [Full Text] [Related]

  • 5. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K, Al-Abdulrazzaq D, Fayed A, El Busairi E, Al Shawaf F, Abdul-Rasoul M, Shaltout AA.
    J Pediatr Endocrinol Metab; 2019 Aug 27; 32(8):843-849. PubMed ID: 31318694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin Management for Type 2 Diabetes During Ramadan: A Narrative Review for Clinicians.
    Kieu A, Iles A.
    Curr Diabetes Rev; 2023 Aug 27; 19(3):e170522204910. PubMed ID: 35585815
    [Abstract] [Full Text] [Related]

  • 12. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
    Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, Loh SM, Suryawanshi S, Davies MJ, Girman CJ, Katzeff HL, Radican L, Engel SS, Wolthers T.
    Curr Med Res Opin; 2012 Aug 27; 28(8):1289-96. PubMed ID: 22738801
    [Abstract] [Full Text] [Related]

  • 13. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting.
    Cesur M, Corapcioglu D, Gursoy A, Gonen S, Ozduman M, Emral R, Uysal AR, Tonyukuk V, Yilmaz AE, Bayram F, Kamel N.
    Diabetes Res Clin Pract; 2007 Feb 27; 75(2):141-7. PubMed ID: 16815586
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
    Benbarka MM, Khalil AB, Beshyah SA, Marjei S, Awad SA.
    Diabetes Technol Ther; 2010 Apr 27; 12(4):287-90. PubMed ID: 20210567
    [Abstract] [Full Text] [Related]

  • 17. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022.
    Hassanein M, Binte Zainudin S, Shaikh S, Shaltout I, Malek R, Buyukbese MA, Alfadhli EM, Shaikh K, Hussein Z, Eliana F, Hafidh K, El Toony LF, Fariduddin M, Alabbood M, Batais MA, Akter N, Rosandi R, Odhaib SA, Al Amoudi R, Ahmedani MY.
    Curr Med Res Opin; 2024 Sep 27; 40(9):1515-1523. PubMed ID: 39076065
    [Abstract] [Full Text] [Related]

  • 18. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O, Ertorer ME, Bozkirli E, Tutuncu NB, Demirag NG.
    Acta Diabetol; 2009 Mar 27; 46(1):63-5. PubMed ID: 18825302
    [Abstract] [Full Text] [Related]

  • 19. Risk stratification of persons on premixed insulin in Ramadan.
    Kalra S, Jawad F, Latif ZA, Pathan MF.
    J Pak Med Assoc; 2017 Nov 27; 67(11):1771-1774. PubMed ID: 29171581
    [Abstract] [Full Text] [Related]

  • 20. Diabetes management during Ramadan amid Covid-19 pandemic.
    Tootee A, Esfahani EN, Larijani B.
    Daru; 2020 Dec 27; 28(2):795-798. PubMed ID: 32588340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.